Evaluating high-cost technologies - no need to throw the baby out with the bathwater.

Sagoo, Gurdeep S; Robinson, Tomos; Coughlan, Diarmuid; Meader, Nick; Rice, Stephen; Vale, Luke

Sagoo, Gurdeep S; Robinson, Tomos; Coughlan, Diarmuid; Meader, Nick; Rice, Stephen; Vale, Luke.

Afiliação

Sagoo GS; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Robinson T; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Coughlan D; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Meader N; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Rice S; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Vale L; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.

Expert Rev Pharmacoecon Outcomes Res ; 23(10): 1177-1183, 2023.

Article em En | MEDLINE | ID: mdl-37755333

Assuntos

Avaliação da Tecnologia Biomédica; Tecnologia de Alto Custo; Humanos; Incerteza; Tecnologia Biomédica; Produção de Droga sem Interesse Comercial; Análise Custo-Benefício

Palavras-chave

High-cost technologies; evidence generation; health technology assessment; life-cycle health technology assessment; real-world data

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Tecnologia de Alto Custo Tipo de estudo: Health_economic_evaluation / Health_technology_assessment Limite: Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google